Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Research Scholarships - Master's program

McMaster University

$27,000.00

Using Chemical Biology to Uncover Hidden Bacterial Targets for Antibiotic Discovery

FY 2025-26

Summary
Antibiotic resistance is accelerating faster than our ability to develop new treatments, projected to cause ~39 million deaths by 2050. Exacerbating this problem is our limited understanding of how bacteria rewire their physiology to survive antibiotics. This work tackles this problem directly by mapping the gene expression changes that accompany resistance in Escherichia coli, a WHO priority pathogen with urgent unmet clinical need. I will leverage a powerful high-throughput imaging platform and a fluorescent E. coli reporter library to systematically identify genes that become overexpressed both when bacteria are exposed to sub-lethal antibiotics and when essential drug targets are genetically knocked-down. My central hypothesis is that genes consistently overexpressed under both stresses represent hidden cellular vulnerabilities – single points of failure – that can be exploited as drug targets. First, I will benchmark this strategy using knockdowns of known antibiotic targets and compare them with antibiotic-induced transcriptional responses to identify overexpressed genes. Next, I will validate these genes as drug targets using existing inhibitors, focusing on targets with approved drugs for immediate combination therapy applications. Finally, I will screen diverse compound libraries against validated targets to discover inhibitors that act preferentially when these resistance-linked genes are overexpressed. This integrated chemical-genetic approach will reveal how bacteria adapt to survive antibiotic pressure and will identify and validate new targets for drug discovery. By uncovering vulnerabilities that emerge specifically in the context of resistance, this work provides a roadmap toward developing the next generation of life-saving antibiotics.
Program
Master's Award: Canada Graduate Research Scholarships - Master's program
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
572681
Name
Jin Kevin Y
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Using Chemical Biology to Uncover Hidden Bacterial Targets for Antibiotic Discovery
Programtype2
Studentship Programs
Orgnameinp2
McMaster University
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Research Scholarships - Master's program
Keyworddelim
Antibiotic Discovery; Antimicrobial Resistance; Bacterial Essential Genes; Bacterial Fitness; Bacterial Genetics; Bacterial Physiology; Chemical Genomics; Systems Biology; Target Identification; Target Validation
Abstract
Antibiotic resistance is accelerating faster than our ability to develop new treatments, projected to cause ~39 million deaths by 2050. Exacerbating this problem is our limited understanding of how bacteria rewire their physiology to survive antibiotics. This work tackles this problem directly by mapping the gene expression changes that accompany resistance in Escherichia coli, a WHO priority pathogen with urgent unmet clinical need. I will leverage a powerful high-throughput imaging platform and a fluorescent E. coli reporter library to systematically identify genes that become overexpressed both when bacteria are exposed to sub-lethal antibiotics and when essential drug targets are genetically knocked-down. My central hypothesis is that genes consistently overexpressed under both stresses represent hidden cellular vulnerabilities – single points of failure – that can be exploited as drug targets. First, I will benchmark this strategy using knockdowns of known antibiotic targets and compare them with antibiotic-induced transcriptional responses to identify overexpressed genes. Next, I will validate these genes as drug targets using existing inhibitors, focusing on targets with approved drugs for immediate combination therapy applications. Finally, I will screen diverse compound libraries against validated targets to discover inhibitors that act preferentially when these resistance-linked genes are overexpressed. This integrated chemical-genetic approach will reveal how bacteria adapt to survive antibiotic pressure and will identify and validate new targets for drug discovery. By uncovering vulnerabilities that emerge specifically in the context of resistance, this work provides a roadmap toward developing the next generation of life-saving antibiotics.
Competitiondate
202512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Jin, Kevin Y
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~